John Kenny
Opinion
06 February 2024
•
Despite pharma being the no. 2 category in terms of ad spend in the US, John Kenny, from EVERSANA INTOUCH, discusses the reasons why pharmaceutical ads are usually absent from the Super Bowl.
Opinion
05 February 2021
•
Processes, communication, the standard system of providing healthcare, and especially relationships … it’s all been disrupted by the COVID-19 pandemic. We continue to live and work in a state of evolution and uncertainty. What hasn’t changed, though, is the importance of connections, relationships, and the flow of information between the pharmaceutical industry, healthcare professionals (HCPs), and patients.
Opinion
01 July 2019
•
The world famous, Nobel prize winning, behavioral economist, Daniel Kahneman has spent years reviewing and leading the whole literature on happiness research. Overwhelmingly, it finds that if we really wanted to be happy, we wouldn’t be interested in premium brands at all. All the luxury brands in the world, only contribute to a brief boost in peoples’ happiness, after which, through a process of what is called “the hedonic treadmill” we get used to our new found bling, and quickly return to a relatively stable level of happiness.
About John Kenny
John Kenny is executive vice president, head of strategic planning at EVERSANA INTOUCH. John is responsible for working with the strategic planning team to continually evolve the strategic point of view and approach, while bringing the most innovative and effective solutions to clients’ brands. John has worked in advertising for nearly 20 years, across a range of categories including, most recently, pharma brands in categories as diverse as oncology, rare, dermatology, neurology, and gastroenterology. He has been involved in many Super Bowl campaigns and his work has received numerous creative awards, including a 2022 Cannes Lion Grand Prix in Creative Effectiveness.